Ethics Committee Position Statement

Under the guidance of the International Pediatric Transplant Association (IPTA) Executive Council, the IPTA Ethics Committee was asked to develop a position statement supporting prioritizing pediatric recipients for deceased donor organ allocation. This position statement has been published in the journal Pediatric Transplantation, the official journal of IPTA, on December 5, 2022.
The journal’s editorial staff and publishers have kindly designated the position statement as free content to allow it to be viewed on the journal website without subscription. We would encourage readers to review the position statement in total published

As part of this position statement, IPTA endorses the following policy recommendations:

  1. Within countries or regions that have standardized organ allocation policies, IPTA advocates in favor of prioritizing pediatric recipients for organ allocation. This prioritization should be implemented with acknowledgement of the needs of other stakeholders within the allocation system. IPTA has no singular position on what age threshold should define which potential recipients are considered pediatric patients. Different organs have different age considerations and thresholds. Age considerations should be determined in each jurisdiction and may differ based on the societal norms that differentiate children from adults as well as the technical considerations mandated by clinical constraints. However, the final allocation system should acknowledge the unique benefits experienced by pediatric recipients, the acute need to address pediatric organ failure in a timely manner due to the accrual of significant and sometimes permanent developmental morbidity, and the broader obligations that society has to provide for their health. Within countries or regions where allocation decisions are made by individual programs, we would urge those individuals responsible for organ allocation to consider these factors as well and incorporate those considerations into the allocation process.
  2. Whenever possible, IPTA supports the establishment of transparent, publicly accessible, and formalized allocation systems within local, regional, national and (if applicable) international health systems to minimize disparities in allocation practices that may adversely affect children.
  3. Where technical expertise exists, IPTA supports the use of technical innovations such as split liver transplantation, which will enhance availability of organs for allocation to both children and adults
  4. In order to ensure that these goals are achieved, IPTA recommends the engagement of individuals with expertise in pediatric transplantation in the process of developing and regularly updating local, regional, or national organ allocation policies whenever possible.

Michael A. Freeman, Jean Botha, Eileen Brewer, Mihaela Damian, Robert Ettenger, Katheryn Gambetta, Debra S. Lefkowitz, Lainie Friedman Ross, Riccardo Superina, Mignon I. McCulloch and Tom Blydt-Hansen on behalf the IPTA Ethics Committee

Statement Supporting the Prioritization of Pediatric Recipients for Deceased Donor Organ Allocation

Organ transplant remains the optimal therapy for a wide variety of diseases that affect both adults and children. Unfortunately however, these organs are an inherently scarce resource and as such, developing the most appropriate allocation schema is a challenging ethical question. Prioritization of children for deceased donor organ allocation is implemented in some, but not most jurisdictions internationally. The reasons for this disparity may differ between different transplant centers and health systems. This document will address the clinical and ethical imperatives in support of pediatric priority in organ allocation.

The International Pediatric Transplant Association is a professional organization of individuals in the field of pediatric transplantation, whose goal is to advance the science and practice of pediatric transplantation worldwide, in order to improve the health of all children with end-stage organ failure. Given this expertise, we feel that our organization is uniquely suited to frame and discuss the ethical arguments relating to the need and value of pediatric recipients priority for organ allocation.

As an international organization, we acknowledge that individual arguments for pediatric prioritization must be considered within the context of existing medical infrastructure and social consensus regarding organ allocation in a given health setting. Additionally, we acknowledge a variety of competing ethical principles and concepts guide organ allocation, including understandings of equity and fairness in waiting time, medical urgency for those circumstances in which no suitable support therapies are available, utility in selecting recipients with the best predicted outcomes, and a desire to ensure that the limited resource of transplantable deceased donor organs is used in circumstances where there is confidence that the recipient will derive a meaningful and sustained benefit. As such, while we support the relative prioritization of pediatric recipients for deceased donor organ allocation, the implementation of that prioritization will be different depending on the organ in question, the prevailing allocation process, and on the resource constraints.

In health care environments where prioritization of pediatric recipients for organ allocation is not feasible, due to limitations of economic, social, or medical resources, IPTA supports efforts to address these limitations whenever possible.

This position statement will review a variety of ethical arguments for pediatric prioritization for organ allocation, arguments that reflect the array of underlying values that may influence current organ allocation procedures in a given locale.
1. The medical urgency of organ transplant in the pediatric population
2. Increased utility of organ transplantation in the pediatric population
3. The fair innings argument
4. Societies’ special obligations to children
Given these arguments, IPTA has the following policy recommendations:

References

Full position statement is published in the Pediatric Transplantation Journal

IPTA Ethics Committee - Member Feedback

IPTA Member Feedback

Invalid Input
Invalid Input
Invalid Input

Social

Contact

Staff Directory
+1-514-874-1717 x216
sections@tts.org

Address

Cell Transplant and Regenerative Medicine Society
c/o The Transplantation Society
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada